Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 23, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 25, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001837796-26-000002
Filed / recorded
Feb 25, 2026, 9:16 PM UTC
Added to OQRO
Oct 6, 2026, 7:59 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
Hims & Hers Health, Inc.
Issuer CIK
1773751
Ticker
HIMS
Reporting person
Andrew Dudum
Relationship
Director, Officer, 10% owner
Officer title
Chief Executive Officer
Security
Class A Common Stock
Table
Non-derivative (Table I)
Transaction date
Feb 23, 2026
Transaction code
A
Shares / units
794,002
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,672,734
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents performance-based restricted stock units (PRSUs) earned pursuant to a previously granted award. Each PRSU represents a contingent right to receive one share of the Company's Class A common stock. The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award had been met as of February 23, 2026. In accordance with the award's terms, the shares underlying the PRSUs will be delivered to the Reporting Person on or about March 15, 2026.